becca - the real death knell is CELG could stop funding this tiny company. Without CELG this is a shell company IMO.
No reason for MDXG to bother with this company that operates at a loss and has zero reimbursement process
Really insightful penny
ZIOP made 1.3 million in revenue last year and the other 3 are pharma companies
Keep illustrating to everyone here how little you know or understand what MDXG does
Please keep shorting ....
Be careful when you imply an impending FDA approval (which I believe is close at hand)
Our resident "board cop" home_b will be compelled to call you on your nonsense observations.
don't count on it
half the time you find out more on these message boards that what the company offers for press releases
buying more here and can't wait for the greedy shorts to get the shares they want to cover so we can more on
I agree with you earth. Management has a fresh opportunity to rebrand how they will go about dealing with the lies and PPS manipulation
Of particular interest is the company's past comments regarding knowledge to who or whom is behind a good deal of this manipulative mess
I expect the company will elaborate more on this topic next week
No buy back will be needed if the company does what they say and expose the D-bags that have been shorting the stock and spreading lies
on top of that 1000 shares sold upon that press release pre market ... just confirms the smoke and mirrors game that I hope the company can address as they have suggested.
100k fresh new possible customers
MiMedx also announced that it has entered into a national agreement with Novation.
Novation is the country's leading health care services company for the more than 100,000 members and affiliates of VHA Inc., UHC, Children's Hospital Association, and Provista LLC
I thought MDXG was the "market leader?"
I never understand why a company that has half our market cap and a small upgrade from Piper J would get more media publicity that MDXG?
The goons on CNBC even admitted they had "no idea what OSIR does"
....further complicating the situation is that it's becoming cheaper to short the stock. On my end at least, it's still hard to borrow but the cost went down 50bps.
I have only one question for management re. shareholders meeting.
Guys, ego's aside, our company has a terrific story and the numbers speak for themselves. WHY do we fail to receive the enforcement of large, well respected institutions like JP Morgan?
The reason why MDXG will get this transition letter is because the FDA has a history of doing a "moon walk" on topics that are market leading and breakthrough technologies. The injectable has ZERO adverse effects and all this is FACT.
Look for instance at our own MDXG achieving FDA APPROVAL (documented on their web site) for the marketing of the injectable, only to see the FDA to re-evaluate and provide the untitled letter.
As for MDXG being a "held bomb" recall the short began in earnest when the stock was around $1.00, having made the transition from the pink sheets to nasdaq.
The "short pain" is VERY far reaching already and the best way they've learned to make money now is to "trade" the stock for short gains. I can't wait to see when the "pins are flipped" and the shorts see their "thesis" implode.
Pass through expired for OSIR in December as well but not a mention of that. To me that would be bigger news
silverfox take a look at the analysis reported on seeking alpha, July 10, 2014
also notice the newest article on May 8 bringing light to possible legal problems for sleezy sales practices over at OSIR
str8 I like your enthusiasm however forget about a breakout
I've been a long term long but now ready for the index reshuffle create the predictable "bomb" in July.
Don't believe me, look at last year
Petit is a master of the numbers however John and Randall should receive all the credit for saving this company with their proprietary technology. I'm glad they got paid handsomely.